Recipient pretreatment permits long-term xenograft survival on a relatively low dose cyclosporine maintenance therapy.
Bouwman
E
E
Department of Surgery, Erasmus University, Rotterdam, The Netherlands.
de Bruin
R W
RW
Jeekel
J
J
Marquet
R L
RL
D000818:Animals; D003131:Combined Modality Therapy; D006224:Cricetinae; D003520:Cyclophosphamide / Q000627:therapeutic use; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006085:Graft Survival; D016027:Heart Transplantation / Q000276:immunology*; D007165:Immunosuppression Therapy / Q000379:methods; D008297:Male; D008647:Mesocricetus; D051381:Rats; D011917:Rats, Inbred Lew; D013156:Splenectomy; D014183:Transplantation, Heterologous / Q000276:immunology*; D014916:Whole-Body Irradiation
D016572:Cyclosporine; D003520:Cyclophosphamide